Welcome to the 13th annual DPHARM, Disruptive Innovations to Modernize Clinical Research!
Stop by our table for a hands-on demo of our SENSORA™ Platform to learn how Eko's digital stethoscopes and AI-assisted software support clinical trials, both in-clinic and at-home decentralized clinical trials, through:
- AI-enabled point-of-care disease detection for highly scalable study recruiting.
- Low-burden cardiac patient screening for optimized study enrollment.
- Longitudinal clinical assessment and safety monitoring.
SENSORA™ rapidly identifies structural heart murmurs within seconds, leveraging the familiar clinical instrument, the stethoscope. Our cutting-edge machine learning algorithms, validated in clinical settings with a remarkable 90% sensitivity rate, represent a significant advancement compared to conventional methods. 1,2,3 With over 1 million heart sounds analyzed to date, Eko has transformed the stethoscope into a powerful tool for gathering objective cardiac insights.
Chris Economos, VP of Life Sciences, will represent Eko Health at the DPHARM Idol Disrupt, a series with quick-fire presentations showcasing bold and daring startups pitching their disruptive technologies to the most discerning judges.
Stop by the DPharm Idol Disrupt at 4:40 pm in the Westin Copley Place to hear Chris present Eko Health's revolutionary work, focusing on the theme: "Rethink the stethoscope for clinical trials."
Interested? Schedule a meeting with Chris below.
